Intended for healthcare professionals

CCBYNC Open access

Research

Industry sponsorship bias in cost effectiveness analysis: registry based analysis

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-069573 (Published 22 June 2022) Cite this as: BMJ 2022;377:e069573

Linked Editorial

Promoting confidence in cost-effectiveness analyses

EditorialPromoting confidence in cost-effectiveness analyses

Cited by...

Reporting Quality in Health Economic Evaluation Studies of Immune Checkpoint Inhibitors: A Systematic Review
- Abstract
- Fulltext
- PDF
Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic review
- Abstract
- Fulltext
- PDF
Examining our failings
- Abstract
- Fulltext
- PDF
Promoting confidence in cost-effectiveness analyses
- Abstract
- Fulltext
- PDF

See other articles in issue 8342

Article tools

PDF 2 responses

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

View ORCID ProfileFeng Xie professor, Ting Zhou postdoctoral fellow

Xie F, Zhou T. Industry sponsorship bias in cost effectiveness analysis: registry based analysis BMJ 2022; 377 :e069573 doi:10.1136/bmj-2021-069573

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions